Earnings History Data for Rallybio (RLYB) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Rallybio

Rallybio Corporation is a clinical-stage biotechnology company committed to identifying and accelerating the development of therapies for patients with severe and rare diseases. Rallybio Corporation is headquartered in New Haven, Connecticut.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-11-2024	PM		RLYB	Rallybio	42.00	-0.26	-0.36	0.00	Rallybio GAAP EPS of -$0.26 beats by $0.09, revenue of $0.3M [11/7/2024 1:44 PM]	0.9911	-0.01 (-0.89%)	1.00	0.0 (0.00%)	0.96 - 3.62	80,322	70,000	3,921
Rallybio GAAP EPS of -$0.26 beats by $0.09, revenue of $0.3M [11/7/2024 1:44 PM] Rallybio Reports Third Quarter 2024 Financial Results and Provides Business Updates [2024-11-07 08:00AM]
08-08-2024	PM		RLYB	Rallybio	50.00	-0.37	-0.42	0.00		1.20	0.0 (0.00%)	0.0	0.0 (0.00%)	1.09 - 6.33	21,134	100,000	0

09-05-2024	PM		RLYB	Rallybio	73.00	-0.47	-0.50	0.00	Rallybio reports Q1 results [5/9/2024 12:31 PM]	1.89	0.04 (2.16%)	1.90	0.05 (2.70%)	1.23 - 9.14	160,483	250,000	2,744
Rallybio reports Q1 results [5/9/2024 12:31 PM]
12-03-2024	PM		RLYB	Rallybio Corporation	70.30	-0.50	-0.44	-0.46	Rallybio GAAP EPS of -$0.50 [3/12/2024 9:49 AM]	1.68	-0.17 (-8.97%)	1.84	0.0 (0.00%)	1.23 - 9.14	126,588	170,000	5,026
Rallybio GAAP EPS of -$0.50 [3/12/2024 9:49 AM]
09-11-2023	PM		RLYB	Rallybio	130.00	-0.45	-0.51	0.00	Rallybio GAAP EPS of -$0.45 [11/9/2023 12:28 PM]	3.04	0.04 (1.33%)	0.0	0.0 (0.00%)	2.85 - 9.88	114,694	70,000	0
Rallybio GAAP EPS of -$0.45 [11/9/2023 12:28 PM]
08-08-2023	PM		RLYB	Rallybio	224.00	-0.46	-0.48	0.00	Rallybio GAAP EPS of -$0.46 [8/8/2023 10:19 AM]	5.18	-0.32 (-5.82%)	0.0	0.0 (0.00%)	4.15 - 15.89	26,220	40,000	0
Rallybio GAAP EPS of -$0.46 [8/8/2023 10:19 AM]
06-03-2023	PM		RLYB	Rallybio	251.00	-0.46	-0.63	0.00	Rallybio GAAP EPS of -$0.46 beats by $0.14 [3/6/2023 9:28 AM]	8.78	0.85 (10.66%)	0.0	0.0 (0.00%)	4.54 - 15.89	81,499	40,000	0
Rallybio GAAP EPS of -$0.46 beats by $0.14 [3/6/2023 9:28 AM]
07-11-2022	PM	8:00 AM ET (Nov 7)	RLYB	Rallybio	270.00	-0.60	-0.54	0.00	Rallybio GAAP EPS of -$0.60 misses by $0.06 [11/7/2022 8:41 AM]	8.86	0.24 (2.73%)	0.0	0.0 (0.00%)	5.90 - 21.00	28,731	60,000	0
Rallybio GAAP EPS of -$0.60 misses by $0.06 [11/7/2022 8:41 AM] Rallybio sees positive results in phase 1 trial of complement-mediated diseases candidate [11/7/2022 9:25 AM] Rallybio Reports Third Quarter 2022 Financial Results [Nov-07-22 08:00AM] Rallybio Announces Positive Phase 1 Single Ascending Dose Results for RLYB116, an Innovative Subcutaneously Injected Inhibitor of Complement Component 5 [Nov-07-22 07:30AM]
08-08-2022	PM	8:00 AM ET (Aug 8)	RLYB	Rallybio	337.00	-0.57	-0.61	0.00	Rallybio GAAP EPS of -$0.57 beats by $0.04 [8/8/2022 8:46 AM]	10.56	-0.69 (-6.13%)	11.25	0.0 (0.00%)	5.90 - 21.00	33,227	40,000	576
Rallybio GAAP EPS of -$0.57 beats by $0.04 [8/8/2022 8:46 AM] Rallybio Reports Second Quarter 2022 Financial Results [Aug-08-22 08:00AM]
10-05-2022	PM	8:00 AM ET (May 10)	RLYB	Rallybio	348.00	-0.48	-0.48	0.00	Rallybio GAAP EPS of -$0.48 misses by $0.01 [5/10/2022 8:58 AM]	11.05	0.97 (9.62%)	10.08	0.0 (0.00%)	6.74 - 25.78	40,943	127,681	1,101
Rallybio in-licenses preclinical antibody candidate from Sanofi [5/10/2022 8:00 AM] Rallybio GAAP EPS of -$0.48 misses by $0.01 [5/10/2022 8:58 AM] Rallybio Reports First Quarter 2022 Financial Results [May-10-22 08:00AM] Rallybio Announces In-Licensing of Potential First-In-Class Preclinical Antibody Candidate from Sanofi [May-10-22 07:30AM]
15-03-2022	PM		RLYB	Rallybio Corporation	310.38	-0.42	0.00	0.00	Rallybio GAAP EPS of -$0.42 misses by $0.01 [3/15/2022 9:09 AM]	8.26	-0.38 (-4.40%)	8.64	0.0 (0.00%)	8.06 - 25.78	241,761	85,391	163
Rallybio Reports Fourth Quarter and Full Year 2021 Financial Results [Mar-15-22 08:00AM]
10-11-2021	PM	7:00 AM ET (Nov 10)	RLYB	Rallybio	609.00	-0.37	-0.89	0.00	Rallybio EPS beats by $0.52 [11/10/2021 9:30 AM]	19.99	1.04 (5.49%)	0.0	0.0 (0.00%)	10.05 - 25.78	83,860	30,000	0
Rallybio EPS beats by $0.52 [11/10/2021 9:30 AM] Rallybio Corporation Reports Third Quarter 2021 Financial Results and Recent Business Highlights [Nov-10-21 07:00AM]